Evidence map›Paper›PMID 38667797›Full record

ReviewMarine drugs2024

Marine-Derived Metabolites Act as Promising Antifungal Agents.

Sijin Hang, Hui Lu, Yuanying Jiang

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Biofungicides Based on Plant Extracts: On the Road to Organic Farming.International journal of molecular sciences · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sijin HangDepartment of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200092 Shanghai, China.
Hui LuDepartment of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200092 Shanghai, China.ORCID 0000-0002-8422-0427
Yuanying JiangDepartment of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200092 Shanghai, China.
Tongji University · CN

Funding

Innovation Program of Shanghai Municipal Education Commission 202101070007-E00094National Key Research and Development Program of China 2021YFC2300404National Key Research and Development Program of China 2022YFC2303004National Natural Science Foundation of China 82020108032
6 · The paper itself

Abstract

The incidence of invasive fungal diseases (IFDs) is on the rise globally, particularly among immunocompromised patients, leading to significant morbidity and mortality. Current clinical antifungal agents, such as polyenes, azoles, and echinocandins, face increasing resistance from pathogenic fungi. Therefore, there is a pressing need for the development of novel antifungal drugs. Marine-derived secondary metabolites represent valuable resources that are characterized by varied chemical structures and pharmacological activities. While numerous compounds exhibiting promising antifungal activity have been identified, a comprehensive review elucidating their specific underlying mechanisms remains lacking. In this review, we have compiled a summary of antifungal compounds derived from marine organisms, highlighting their diverse mechanisms of action targeting various fungal cellular components, including the cell wall, cell membrane, mitochondria, chromosomes, drug efflux pumps, and several biological processes, including vesicular trafficking and the growth of hyphae and biofilms. This review is helpful for the subsequent development of antifungal drugs due to its summary of the antifungal mechanisms of secondary metabolites from marine organisms.

Indexed as

Antifungal AgentsAquatic OrganismsAnimalsBiological ProductsFungiSecondary MetabolismAntifungal AgentsBiological Productsantifungal mechanismsantifungal targetsinvasive fungal diseasesmarine-derived metabolites

Identifiers

PMID38667797
PMCPMC11051449
OpenAlexW4394880612

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.